Ensysce Biosciences (ENSC) Other Accumulated Expenses (2020 - 2025)
Ensysce Biosciences' Other Accumulated Expenses was $993,411 in Q4 2025, up 81.1% from $548,458 a year earlier but down 31.7% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
From Q4 2020 onward, Ensysce Biosciences has reported Other Accumulated Expenses for 20 quarters.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
- In earlier years, Other Accumulated Expenses was $548,458 in FY2024 (+1.1%), $542,260 in FY2023 (-75.6%), $2.23 million in FY2022 (-34.7%) and $3.41 million in FY2021 (+888.3%).
- Quarterly Other Accumulated Expenses has moved between $370,186 (Q2 2024) and $3.73 million (Q3 2021) over five years.
- Compared with a year earlier, Other Accumulated Expenses has increased for five straight quarters, with growth averaging 53.8% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2021 (growth of 888.3%); the worst was Q1 2024 (a decline of 82.7%).
- Per Business Quant data, ENSC's Other Accumulated Expenses in the three quarters before Q4 2025 was $1.45 million (Q3 2025), $1.05 million (Q2 2025) and $888,498 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn |
| 10 | Ensysce Biosciences | 1.25 Mn | -9.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 993,411.00 |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 888,498.00 |
| Dec 31, 2024 | 548,458.00 |
| Sep 30, 2024 | 447,035.00 |
| Jun 30, 2024 | 370,186.00 |
| Mar 31, 2024 | 408,435.00 |
| Dec 31, 2023 | 542,260.00 |
| Sep 30, 2023 | 760,458.00 |
| Jun 30, 2023 | 785,827.00 |
| Mar 31, 2023 | 2.36 Mn |
| Dec 31, 2022 | 2.23 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 3.73 Mn |
| Jun 30, 2021 | 411,941.00 |
| Dec 31, 2020 | 344,792.00 |
API Access
Ensysce Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();